17alpha-alkyl-17beta-oxy-estratrienes, uses thereof and pharmaceutical preparations

Details for Australian Patent Application No. 2004202428 (hide)

Owner Schering Aktiengesellscaft

Inventors Lichtner, Rosemarie; Kroll, Jorg; Heinrich, Nikolaus; Reichel, Andreas; Hoffmann, Jens; Bohlmann, Rolf; Jautelat, Rolf; Petrov, Orlin

Agent Davies Collison Cave

Pub. Number AU-B-2004202428

Parent 2002360949

Filing date 2 June 2004

Wipo publication date 24 June 2004

Acceptance publication date 23 February 2006

International Classifications

C07J 41/00 (2006.01) Normal steroids, i.e. cyclopenta[a]hydrophenanthrenes, containing nitrogen

A61K 31/567 (2006.01) - substituted in position 17 alpha, e.g. mestranol, norethandrolone

A61P 5/32 (2006.01) Drugs for disorders of the endocrine system

C07J 43/00 (2006.01) Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta[a]hydrophenanthrene skeleton

Event Publications

17 June 2004 Complete Application Filed

24 June 2004 Application Open to Public Inspection

  Published as AU-B-2004202428

23 February 2006 Application Accepted

  Published as AU-B-2004202428

22 June 2006 Standard Patent Sealed

9 October 2008 Alteration of Name

  The name of the patentee has been altered to Bayer Schering Pharma Aktiengesellschaft

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004202429-Rotary Motion Tranfer device

2004202427-Sliding door construction